biospecimen_aliquot__bcr_aliquot_barcode	tcga-e9-a295-01a-11d-a16d-09
biospecimen_aliquot__bcr_aliquot_uuid	f3d5e986-046f-4f75-8abc-67a3b99f742d
biospecimen_aliquot__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_aliquot__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113421764
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-06-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a16d
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.89
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e9-a295-01a-11d
biospecimen_analyte__bcr_analyte_uuid	741216a4-dfc2-4958-a8a6-82b1d4a30aaa
biospecimen_analyte__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_analyte__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_analyte__concentration	0.18
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e9-a295
biospecimen_diagnostic_slides__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	ed6cc024-56e7-45a9-b41f-f84550a899f7
biospecimen_normal_control__bcr_patient_barcode	tcga-e9-a295
biospecimen_normal_control__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_portion__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_portion__bcr_portion_barcode	tcga-e9-a295-01a-11
biospecimen_portion__bcr_portion_uuid	d541254e-46d3-4cee-a041-e1350f4107a7
biospecimen_portion__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_portion__date_of_creation	2011-05-25
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e9-a295-01a-11d
biospecimen_protocol__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_protocol__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_sample__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_sample__bcr_sample_uuid	3944bcd6-1a95-4297-8cf3-7e7d38b9390e
biospecimen_sample__days_to_collection	63
biospecimen_sample__initial_weight	670
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e9-a295.a23d86ff-cca9-42b2-b6ae-9e365aac03c8.pdf
biospecimen_sample__pathology_report_uuid	a23d86ff-cca9-42b2-b6ae-9e365aac03c8
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	21dc7633-3a7e-407d-ae43-88edfef05091
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e9-a295-01a-21-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
biospecimen_slide__bcr_sample_barcode	tcga-e9-a295-01a
biospecimen_slide__bcr_slide_barcode	tcga-e9-a295-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	14a39b7e-5d34-43ea-971c-09a8db7694e8
biospecimen_slide__image_file_name	tcga-e9-a295-01a-01-tsa.14a39b7e-5d34-43ea-971c-09a8db7694e8.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	2
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	5
biospecimen_slide__percent_stromal_cells	63
biospecimen_slide__percent_tumor_cells	30
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e9-a295
biospecimen_tumor_sample__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
clinical_drug__bcr_drug_barcode	tcga-e9-a295-d35357
clinical_drug__bcr_drug_uuid	c6ff0a55-dd00-4370-882c-4cda4d7f524d
clinical_drug__bcr_patient_barcode	tcga-e9-a295
clinical_drug__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
clinical_drug__form_completion_date	2012-10-5
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	152
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-e9-a295-f35355
clinical_follow_up__bcr_followup_uuid	3dda0b38-4114-4bcd-8eb4-4d82877cc1fc
clinical_follow_up__bcr_patient_barcode	tcga-e9-a295
clinical_follow_up__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
clinical_follow_up__followup_lost_to	yes
clinical_follow_up__form_completion_date	2012-9-25
clinical_follow_up__last_contact_days_to	375
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	71
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right lower outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e9-a295
clinical_patient__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
clinical_patient__birth_days_to	-25957
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_scale_other	7
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	80-89%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-9-12
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	22
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	7
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a295
clinical_patient__pr_positivity_scale_other	7
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	80-89%
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e9
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e9-a295
clinical_radiation__bcr_patient_uuid	fec0da58-1047-44d2-b6d1-c18cceed43dc
clinical_radiation__bcr_radiation_barcode	tcga-e9-a295-r35358
clinical_radiation__bcr_radiation_uuid	20725e45-0e63-4739-8b3f-414f2bbaac47
clinical_radiation__form_completion_date	2012-9-25
clinical_radiation__radiation_adjuvant_fractions_total	65
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	74
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	46
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	130
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A295-01A-11D-A16D-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A295-01A-11D-A16D-09.bed.meta
manually_curated__id	tcga-e9-a295-01a-11d-a16d-09
manually_curated__md5sum	7560ea9e4e514fb59e1de7c63af876f9
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	f3d5e986-046f-4f75-8abc-67a3b99f742d
manually_curated__tumor_tag	brca
